Table 2 Clinical outcomes and complications
From: Palliative enteral feeding for patients with malignant esophageal obstruction: a retrospective study
NG tube | Esophageal stent | NPO | P-value | |
|---|---|---|---|---|
(n = 12) | (n = 10) | (n = 9) | ||
Albumin, g/dL | 3.1 ± 0.5 | 3.0 ± 0.5 | 2.1 ± 0.4 | <0.01 |
EN intake, dL/day | 11.8 ± 4.9 | 10.9 ± 3.5 | 3.6 ± 1.9 | 0.01 |
IV fluid volume, dL/day | 9.9 ± 4.9 | 9.4 ± 3.7 | 13.5 ± 3.3 | 0.08 |
LOH, days | 19 ± 15 | 12 ± 11 | 39 ± 18 | 0.01 |
Survival, days | 122a | 133a | 51 | <0.01 |
Complications | 22 | 21 | 9 | |
Aspiration pneumonia | 7b | 5b | 9 | 0.38 |
Dislodgment | 7c | 2c | 0 | 0.01 |
Chest pain | 2 | 3 | 0 | 0.21 |
Perforation | 0 | 0 | 0 | |
Hemorrhage | 0 | 0 | 0 |